Mobile-health Network Solutions Intends To Acquire Lifepack, Expanding into Indonesia's Growing Healthcare Market
Singapore, Singapore--(Newsfile Corp. - April 30, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ('MNDR' or 'the Company'), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today announced an agreement intending to acquire Indopacific Health Technology Pte. Ltd. and its subsidiaries, known as Lifepack, a leading pharmacy and telehealth platform in Indonesia ('Acquisition').
Focus on Indonesia
'This acquisition is a significant step for MNDR as we expand into Indonesia, a high-growth market,' said Dr. Siaw Tung Yeng, PBM, Co-CEO and Senior Consultant Family Physician at MNDR. 'Lifepack's platform aligns with Indonesia's primary care needs and complements our telehealth expertise. Through this partnership, we're building a telehealth-pharmacy solution that meets BPOM (Indonesian National Agency of Drug and Food Control) standards, serving 280 million people across 17,000 islands. We look forward to completing due diligence and finalizing this deal.'
The Acquisition, added Dr. Siaw, would allow MNDR to combine its global telehealth platform with Lifepack's local expertise to serve many of Indonesia's primary care needs, including improved teleconsultations, prescription fulfillment, and healthcare delivery to remote areas, while emphasizing immunization, nutrition, and chronic disease management.
Dr. Siaw further commented, 'By combining Lifepack's strong presence and understanding of the Indonesian market with MNDR's innovative telehealth capabilities, we believe we can create a truly transformative O2O healthcare platform that addresses the unique needs of Indonesian's diverse population and significantly impact healthcare delivery across the archipelago.'
Lifepack: Enhancing Indonesia's Primary Care
Lifepack improves healthcare access in Indonesia, the fourth most populous nation globally, with over 280 million people and a growing demand for affordable medical services. Lifepack's hybrid model delivers BPOM-licensed prescription drugs, over-the-counter medications, supplements, and medical equipment through online and offline channels, serving millions nationwide. Lifepack also offers consultations with physicians and pharmacists, available via its mobile app and website, through WhatsApp and social media, and at physical locations, supported by an expanding warehouse network, to address chronic disease management and preventive care.
Compliant with Indonesia's BPOM regulations, Lifepack's scalable platform and steady user growth position it to lead the Indonesian digital pharmacy market. By supporting primary care needs, especially in remote and rural areas, Lifepack is a key part of MNDR's regional strategy.
MNDR would acquire Lifepack for up to US$7.2 million, contingent upon Lifepack achieving its revenue target for 2025. The consideration for the Acquisition is expected to be satisfied through the issuance of up to 875,000 new MNDR Class A Ordinary Shares, valued at an issue price of US$8 per share, alongside a non-refundable cash payment of US$0.2 million. The US$8 per share issue price represents a substantial premium to MNDR's current share price of approximately US$1.42 as of April 29, 2025, underscoring the perceived value and future potential of the combined entity. Subject to due diligence and execution of definitive agreements, the deal is expected to strengthen MNDR's presence in Southeast Asia through partnerships with Indonesian healthcare stakeholders.
'We look forward to completing the current due diligence process and proceeding to the completion of this Acquisition,' said Dr. Siaw.
About Mobile-health Network Solutions
Ranked #41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies, we are the first telehealth provider from the Asia-Pacific region to be listed in the US. Through our platform, we offer personalized and reliable medical attention to users worldwide. Our platform allows our community of healthcare providers to have broader reach to users through virtual clinics without any start-up costs and the ability to connect to a global network of peer-to-peer support groups and partners. Our range of seamless and hassle-free telehealth solutions includes teleconsultation services, prescription fulfillment and other personalized services such as weight management programs and gender-specific care. For more information, please visit our website.
About Lifepack
Lifepack is a pharmacy service that offers a variety of over-the-counter medications, prescription drugs, supplements, and medical equipment at affordable prices. The company provides original products, licensed by BPOM, and delivers across Indonesia. Lifepack services are available both online and offline, accessible through its website, social media channels, WhatsApp, and its mobile app.
FORWARD-LOOKING STATEMENTS
Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.
For media inquiries, please contact:
Mobile-health Network Solutions
2 Venture Drive, #07-06/07 Vision Exchange Singapore 608526
(+65) 6222 5223
Email: [email protected]
Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5 th Floor
New York, New York 10036
Office: (646) 893-5835
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250291
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Trump says Xi agreed to restart flow of crucial minerals, but analysts say China won't give up its ‘rare earth card'
US President Donald Trump said Chinese leader Xi Jinping has agreed to restart the flow of crucial rare earth materials, after announcing a new round of US-China trade talks will be held in London on Monday. Trump made the comments a day after holding his long-awaited phone call with Xi, during which the two leaders agreed to resume negotiations stalled over mutual accusations of violating the truce reached in Geneva last month. For Washington, a major sticking point has been China's export restrictions on rare earth minerals and magnets, which are essential for everything from cars to fighter jets, and critical to American industries and defense. In the weeks since the fragile detente, Washington has accused Beijing of slow-walking approvals for rare earth exports and reneging on its promise made in Geneva, with Trump expressing increasing urgency to speak to his Chinese counterpart to iron things out. After a 90-minute call on Thursday, Trump said he and Xi had 'straightened out' some points related to rare earth magnets, describing it as 'very complex stuff.' But he did not specify what exactly had been agreed upon. Asked Friday if Xi had agreed to restart the flow of rare earth minerals and magnets, Trump told reporters abroad Air Force One: 'Yes, he did.' He did not further elaborate on how fast that would happen, or the volume of the materials that would be released. The Chinese readout of the call did not mention rare earths. Instead, it quoted Xi as saying that China had 'seriously and earnestly' complied with the trade truce agreement. Asked about it at the Chinese foreign ministry's daily briefing on Friday, a spokesperson sidestepped the question, saying it was a matter for other agencies to address. China, which controls 90% of the global processing of rare earths, imposed export restrictions on some minerals and magnets on April 4 at the height of the tariff war, after Trump slapped 'reciprocal' levies on Chinese goods. The new system does not ban exports outright, but requires government approval for each shipment. Chinese scholars who advise the government suggested on Thursday that Beijing is not ready to give up the powerful leverage bestowed by its dominance on the rare earth supply chain – and may seek to use it to get Washington to ease its own export controls aimed at blocking China's access to advanced US semiconductors and technologies. While American businesses are likely to see more shipments approved in the next couple of weeks, the export licensing regime is here to stay, said Wu Xinbo, director of the Center for American Studies at Fudan University in Shanghai. He noted that, according to official rules set by China's Commerce Ministry, applications for export licenses can take up to 45 working days to be approved. 'In principle, I can agree to export to you, but I can speed things up or slow them down. In reality, on a technical level, it also depends on the overall bilateral trade and economic atmosphere,' he said. 'If the bilateral relationship is good, then I'll go a bit faster; if not, I'll slow down. But you can't say I'm violating the agreement – I'm still following the standard procedures.' Some Chinese suppliers of US companies have recently received six-month export licenses, the American Chamber of Commerce in China said Friday, but it noted that uncertainty remains amid a large backlog of license applications. Jin Canrong, a professor of international relations at Renmin University in Beijing, said the importance Trump attaches to rare earths shows how effective China's 'rare earth card' is. 'I hadn't realized just how important this rare earth card was before. Now the US side is clearly anxious and eager to resolve this issue,' he said in a video on social media on Thursday. 'But of course, we'll link this issue to others – the US is restricting China on chips and jet engines, then China certainly has every reason to make use of this card.' 'As for whether China will change its rare earth export control policy, that probably still needs to be negotiated in more detail' Jin added. Some Chinese scholars have expressed hope that US technology restrictions on China may now be up for negotiation, after Trump announced that Commerce Secretary Howard Lutnick – whose department overseas US export controls – will join Treasury Secretary Scott Bessent and Trade Representative Jamieson Greer in the next round of trade talks. 'The issue of US export controls may no longer be an area that is completely non-negotiable in the future,' Cui Fan, an economics professor at the University of International Business and Economics in Beijing and advisor to the Chinese Commerce Ministry, wrote in a social media post. Beijing has insisted that its export controls are in line with international practices, non-discriminatory and not targeted at any specific country. Hours before the two leaders jumped on the phone on Thursday, a spokesperson for China's commerce ministry reiterated that stance at a regular news conference, citing the 'clear dual-use attributes' of rare earth materials. Dual-use items refer to those with both civilian and military applications. 'The Chinese government reviews export license applications for dual-use items in accordance with laws and regulations, and for applications that meet the requirements, China will grant approval to promote and facilitate compliant trade,' spokesperson He Yongqian said. The strict licensing system has significantly disrupted the global supplies of these materials and triggered production turmoil across industries in America and Europe, raising alarms among officials and businesses alike. A survey of member companies conducted by the American Chamber of Commerce in China late week found that, among those affected by rare earth export controls, 75% say their stock would run out within three months. CNN's Kit Maher contributed to reporting.
Associated Press
17 minutes ago
- Associated Press
Aura Announces Public Filing of Registration Statement for Proposed U.S. Public Offering
ROAD TOWN, British Virgin Islands, June 06, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) ('Aura' or the 'Company') announces that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the 'SEC') relating to a proposed public offering of its securities in the United States. The proposed public offering includes the registration and listing of our common shares in the United States. The public offering is expected to commence after the SEC completes its review processes, subject to market and other conditions. The number of common shares to be sold and the price range for the proposed offering have not yet been determined. There will be no pre-emptive right for our shareholders and our Brazilian Depositary Receipts holders in connection with the public offering. Aura has applied to list its common shares on the Nasdaq Global Select Market under the symbol 'AUGO.' The U.S. listing is part of Aura's strategy to unlock value for our shareholders, improve stock liquidity and consolidate the liquidity in the U.S. equity market. BofA Securities and Goldman Sachs & Co. LLC are acting as Global Coordinators, BTG Pactual and Itaú BBA are acting as Joint Bookrunners and Bradesco BBI, National Bank of Canada Financial Markets, RBC Capital Markets and Scotiabank are acting as Co-Managers of the offering. The offering will be made only by means of a prospectus. Copies of the preliminary prospectus related to the offering may be obtained, when available, from BofA Securities, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department. A registration statement relating to this offering has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This communication to the market shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. The offering will not be carried out by any means that would constitute a public offering in Brazil under Law No. 6,385, dated December 7, 1976, as amended, and under Brazilian Securities Commission ('CVM') Resolution ( Resolução ) No. 160, dated July 13, 2022, as amended ('CVM Resolution 160'). The offering has not been and will not be registered with the CVM in Brazil. The common shares may not be offered or sold in Brazil except in circumstances which do not constitute a public offering for distribution under Brazilian securities laws and regulations. Caution Regarding Forward-Looking Information and Statements This press release includes certain statements and information that may constitute 'forward-looking information' within the meaning of applicable Canadian securities laws and/or 'forward-looking statements' within the meaning of applicable United States securities laws (collectively, 'forward-looking statements'). Forward-looking statements relate to future events or future performance and reflect the Company's current estimates, predictions, expectations or beliefs regarding future events and include, without limitation, statements with respect to: statements relating to the public offering of the Company's common shares; the expected timing of the public offering; the registration and listing of the Company's common shares in the United States; the registration statement becoming effective; the SEC's review process; the sizing and pricing of the offering; the means by which the offering will be made; and the Company's business strategies. Often, but not always, forward-looking statements may be identified by the use of words such as 'expects', 'anticipates', 'plans', 'projects', 'estimates', 'assumes', 'intends', 'strategy', 'goals', 'objectives' or variations thereof or stating that certain actions, events or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved, or the negative of any of these terms and similar expressions. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements in this press release are based upon, without limitation, the following estimates and assumptions: the Company carrying out its public offering; the Company successfully completing the SEC review process; obtaining requisite regulatory approvals; and general business, economic and market conditions. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Important factors that may cause actual results to vary, include, without limitation, that the Company may not carry out its public offering or complete the SEC review process. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement or forward-looking information, except in accordance with applicable securities laws. Investor Relations [email protected]
Yahoo
17 minutes ago
- Yahoo
Bernstein Maintains a Market Perform Rating on Etsy (ETSY), Sets Price Target at $45
Bernstein SocGen Group maintained a Market Perform rating on Etsy, Inc. (NASDAQ:ETSY) with a price target of $45 on June 5. The analysts observed that growing investor confidence and potential short covering led Etsy shares to climb 32% since last month. A young woman shopping for a vintage fashion item online. Bernstein analysts noted that the upward momentum in Etsy, Inc. (NASDAQ:ETSY) stock is due to stronger alternative data indicating a slowdown in the annual decline of Gross Merchandise Sales in May. This data demonstrates an optimistic outlook for Etsy's growth, particularly compared to its prior lower trading multiples. The stock has gained significant ground, rising 16.15% over the last week and 16.37% so far this year. Although the main driver of this upward swing in the stock remains unclear, the analysts commented that lower traffic for Temu, an Etsy competitor, in May could be a catalyst. They also said that possible changes in products listed at Etsy could be behind this positive trajectory. The report pointed to stronger credit card spending in May and a rise in monthly app usage for Etsy, Inc. (NASDAQ:ETSY), which coincided with Temu witnessing a 43% drop in active users year-over-year. Although the analysts acknowledged that their data might not perfectly match Etsy's reported Gross Merchandise Sales, the overall signals suggest things are moving in a positive direction. Etsy, Inc. (NASDAQ:ETSY) runs global online marketplaces that bring together buyers and sellers through its main platform, Etsy, as well as Reverb for musical instruments and Depop for fashion resale. While we acknowledge the potential of ETSY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. Read Next: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
